Medicare Procedure and Patient Information
Conditions of Medicare patients treated by Dr. Han A. Koh, MD in 2013
The most common conditions of Medicare patients that Dr. Han A. Koh, MD treated during 2013 were hypertension.
65 | |
(No ratings)
Dr. Han A. Koh, MD is an oncologist in Bellflower, CA specializing in adult oncology and adult hematology. He graduated from St. Louis University School of Medicine in 1990 and has 34 years of experience. Dr. Han A. Koh, MD is affiliated with FACULTY PHYSICIANS AND SURGEONS OF LLUSM.
9400 Rosecrans Avenue
Bellflower, CA 90706
The most common conditions of Medicare patients that Dr. Han A. Koh, MD treated during 2013 were hypertension.
Hypertension | 65 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The most common conditions of Medicare patients that Dr. Han A. Koh, MD treated during 2018 were hypertension.
Hypertension | 75 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The most common conditions of Medicare patients that Dr. Han A. Koh, MD treated during 2019 were high cholesterol and chronic kidney disease.
Hypertension | 0 |
---|---|
High Cholesterol | 65 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 55 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
Volume of procedures performed by Dr. Han A. Koh, MD for Medicare patients.
doctor visit | 79 |
---|
Volume of procedures performed by Dr. Han A. Koh, MD for Medicare patients.
doctor visit | 79 |
---|
The highest averages of the most common conditions of Medicare patients that Dr. Han A. Koh, MD treated were hypertension, high cholesterol and chronic kidney disease.
Hypertension | 15 |
---|---|
High Cholesterol | 7 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 6 |
Asthma | 0 |
Osteoporosis | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Atrial Fibrillation | 0 |
Cancer | 0 |
Dementia | 0 |
Dr. Han A. Koh, MD graduated from St. Louis University School of Medicine in 1990. He is certified by the American Board of Internal Medicine - Internal Medicine and has a state license in California.
Medical School: St. Louis University School of Medicine (1990)
Board Certification: American Board of Internal Medicine - Internal Medicine
Licensed In: California
Dr. Han A. Koh, MD is associated with these hospitals and organizations:
Dr. Han A. Koh, MD does not have any reviews yet, be the first to leave a review of Dr. Han A. Koh, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Han A. Koh, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
F. Hoffmann-La Roche AG |
$7,049
Avastin $7,049 |
||
---|---|---|---|
ARIAD Pharmaceuticals, Inc. |
$1,344
$1,344 |
||
Eli Lilly and Company |
$1,252
$1,252 |
||
Bayer HealthCare Pharmaceuticals Inc. |
$884
Stivarga $884 |
||
Roche Products Limited |
$530
$530 |
||
Other |
$36
myRisk $15 |
Clinical Trials Matching $12 |
IBRANCE $9 |
Consulting Fee | $7,049 |
---|---|
Travel and Lodging | $1,995 |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,344 |
Food and Beverage | $698 |
Education | $9 |
Dr. Han A. Koh, MD has received 230 research payments totaling $2,815,738.
Dr. Han Koh sees patients in Bellflower, CA. His medical specialties are adult hematology and adult oncology. Dr. Koh is a graduate of St. Louis University School of Medicine.